HHS releases first draft of National Alzheimer's Plan

The release of the first draft of the National Alzheimer's Plan is another positive step toward the nation's first ever strategic plan for Alzheimer's. Comprehensive in scope, the draft plan addresses issues that are important to the Alzheimer's community including developing new treatments that prevent and effectively treat the disease, delivering much needed support for families, and enhancing care quality and effectiveness.

The release of today's draft plan comes following the Obama Administration's important announcement earlier this month of committing new resources in the fight against Alzheimer's – an initial investment that is necessary to address the broad impact of this disease.

As this draft plan is revised, the Alzheimer's Association urges the Administration to specify the level of commitment and investment that will be needed to meet the goal to prevent and effectively treat the disease by 2025. The Alzheimer's Association values the initial plan's attention to evaluation and assessment, but looks forward to moving quickly from assessment of current efforts and programs to action for the growing number of families touched by the disease.

With engagement from the Advisory Council on Alzheimer's Research, Care and Services and the commitment of the U.S. Department of Health and Human Services, the Alzheimer's Association is confident a final National Alzheimer's Plan will emerge later this spring that accelerates government efforts, indicates the future commitments that will be needed, and encourages public-private partnerships to change the trajectory of one of the nation's most feared diseases.

SOURCE Alzheimer's Association

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.